Regeneus to be granted key Progenza patent in Europe
15/03/2021 21:56
Australia Stock Exchange release from REGENEUS LTD RGS.AX : Regeneus to be granted key Progenza patent in Europe
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology